Article

Bilirubin kinetic modeling for quantification of extracorporeal liver support.

Institut of Physiology, Center for Physiological Medicine, Medical University of Graz, Graz, Austria.
Blood Purification (Impact Factor: 2.06). 02/2006; 24(4):413-22. DOI: 10.1159/000094575
Source: PubMed

ABSTRACT To provide a measure of treatment dose for extracorporeal liver support (ELS).
The kinetics of conjugated bilirubin were described by a two-compartment model (Vc, Vp) with central elimination (K) and constant generation rate (G). The transfer of solute between compartments was modeled by intercompartmental clearance (Kpc). The central compartment (Vc) was assumed as a constant fraction of total volume (Vc = 0.3*Vt).
Eight patients were studied during 35 treatments lasting 6 h each. The average K, Vt, Kpc, G, and mass of conjugated bilirubin removed were 18.6 +/- 3.9 ml/min, 9.1 +/- 3.8 liters, 103 +/- 108 ml/min, 0.33 +/- 0.15 mg/min, and 641 +/- 275 mg, respectively. The reduction ratio (48 +/- 10%) measured as the change in post- to pre-treatment concentrations underestimated the modeled fraction of bilirubin mass removed (54 +/- 13%) essentially because of significant conjugated bilirubin appearance during treatments.
Kinetic analysis provides an improved measure of treatment dose as generation, distribution, and elimination of conjugated bilirubin are jointly considered.

0 Bookmarks
 · 
113 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Im Frühjahr 2010 wurden erneut 2 Studien präsentiert, die keine Verbesserung der Sterblichkeit der Patienten mit akut-auf-chronischem Leberversagen zeigten, obwohl sie mit einem Leberunterstützungssystem behandelt wurden. Die Autoren dieses Beitrags schlagen als Ursache für die negativen Studienergebnisse eine unzureichende Entgiftungsfunktion der Verfahren vor. Am Beispiel der Marker Ammoniak und Bilirubin wird erläutert, welche Entgiftungsziele für eine erfolgreiche Therapie anzusetzen sind. Zusätzlich werden weitere notwendige Funktionen eines Leberunterstützungssystems definiert wie Elektrolytausgleich und Kontrolle des Wasser- und Säure-Basen-Haushaltes. Auf die besondere Bedeutung der Vermeidung von Nebenwirkungen wird hingewiesen, da hierdurch die positiven Ergebnisse der Therapie zunichte gemacht werden können. Weitere offene Fragen betreffen die Auswahl der Patienten, des Therapiebeginns oder die Frage einer intermittierenden vs. einer kontinuierlichen Therapie. In diesem Kontext wird auch der derzeitige Stellenwert bioartifizieller Leberunterstützungssysteme besprochen.
    Intensivmedizin + Notfallmedizin 01/2010; 47(8):576-581.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The elimination of protein-bound solutes during extracorporeal liver support (ELS) therapy involves a sequence of steps and processes such as diffusion, convection, filtration, and adsorption. It was the purpose of this study to analyze the time course and the relative contribution of these processes to overall solute removal. Eighteen treatments done in 8 acute-on-chronic liver failure patients for a duration of 8 h using fractionated plasma separation and adsorption (FPSA) were studied. Conjugated bilirubin was measured in the extracorporeal circulation at 6 different sampling points in regular intervals. Clearance and removal rates were calculated for the whole system and for selected system components. Conjugated bilirubin concentrations decreased in the primary circuit directly connected to the patient and remained stable or increased in the secondary circuit which contained the adsorbers. Bilirubin clearance declined notably during the first 2 h of therapy for the whole system as well as for the adsorbers. The clearance for bilirubin in the primary circuit provided by the FX50 dialyzer was relatively small but constant. In the secondary circuit clearance was larger for the anion exchanger (Prometh02TM) than for the neutral resin (Prometh01TM) and decreased throughout the ELS treatment. Thus, approximately 90% of overall removal rate for conjugated bilirubin occurred in the adsorbers and about 10% in the dialyzer. The information obtained on the relative contribution of different ELS components to overall bilirubin removal could be helpful to improve the performance of selected components of FPSA and thereby of ELS as a whole.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract